nitrilotriacetic acid has been researched along with Congenital Hypocupremia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hurley, LS; Keen, CL; Saltman, P | 1 |
1 other study(ies) available for nitrilotriacetic acid and Congenital Hypocupremia
| Article | Year |
|---|---|
Copper nitrilotriacetate: a potent therapeutic agent in the treatment of a genetic disorder of copper metabolism.
Topics: Animals; Brain Chemistry; Brain Diseases, Metabolic; Copper; Copper Sulfate; Female; Humans; Kidney; Liver; Male; Maternal-Fetal Exchange; Menkes Kinky Hair Syndrome; Mice; Mice, Mutant Strains; Nitrilotriacetic Acid; Pregnancy; Sulfates; Zinc | 1980 |